Your browser is no longer supported. Please, upgrade your browser.
The Cooper Companies, Inc.
IndexS&P 500 P/E6.68 EPS (ttm)58.64 Insider Own0.10% Shs Outstand49.30M Perf Week3.06%
Market Cap18.63B Forward P/E27.67 EPS next Y14.15 Insider Trans-63.82% Shs Float49.02M Perf Month-7.33%
Income2.92B PEG0.67 EPS next Q4.17 Inst Own- Short Float3.61% Perf Quarter-14.12%
Sales2.85B P/S6.55 EPS this Y-47.90% Inst Trans-0.44% Short Ratio6.69 Perf Half Y4.58%
Book/sh137.63 P/B2.85 EPS next Y6.19% ROA27.50% Target Price466.75 Perf Year15.85%
Cash/sh2.36 P/C166.08 EPS next 5Y10.00% ROE41.40% 52W Range327.44 - 463.59 Perf YTD7.77%
Dividend0.06 P/FCF45.23 EPS past 5Y3.00% ROI3.40% 52W High-15.54% Beta0.86
Dividend %0.02% Quick Ratio0.80 Sales past 5Y6.20% Gross Margin66.00% 52W Low19.58% ATR9.73
Employees12000 Current Ratio1.40 Sales Q/Q32.00% Oper. Margin15.80% RSI (14)42.73 Volatility3.33% 2.31%
OptionableYes Debt/Eq0.24 EPS Q/Q1015.60% Profit Margin82.80% Rel Volume3.45 Prev Close377.95
ShortableYes LT Debt/Eq0.17 EarningsDec 02 AMC Payout0.10% Avg Volume264.68K Price391.56
Recom2.30 SMA20-3.37% SMA50-4.69% SMA200-3.46% Volume913,676 Change3.60%
Sep-03-21Reiterated Stifel Buy $450 → $475
Sep-03-21Reiterated Oppenheimer Perform $405 → $475
Sep-03-21Reiterated KeyBanc Capital Markets Overweight $444 → $476
Sep-03-21Reiterated Citigroup Neutral $400 → $453
Apr-23-21Initiated Redburn Buy
Jul-06-20Downgrade Robert W. Baird Outperform → Neutral $291
Mar-05-20Initiated Citigroup Neutral $360
Feb-01-19Upgrade Stephens Equal-Weight → Overweight $305
Jan-04-19Downgrade Goldman Neutral → Sell
Jul-30-18Upgrade KeyBanc Capital Mkts Sector Weight → Overweight
Apr-04-18Initiated Goldman Neutral $231
Dec-08-17Reiterated Stifel Buy $275 → $265
Sep-12-17Reiterated Stifel Buy $265 → $275
Sep-01-17Reiterated Piper Jaffray Overweight $265 → $280
Jul-21-17Downgrade KeyBanc Capital Mkts Overweight → Sector Weight
Jun-29-17Initiated Guggenheim Neutral
Jun-02-17Reiterated Stifel Buy $220 → $231
Dec-12-16Upgrade Wells Fargo Market Perform → Outperform
Sep-02-16Reiterated BMO Capital Markets Outperform $199 → $206
Aug-31-16Reiterated Stifel Buy $195 → $215
Dec-03-21 10:11AM  
Dec-02-21 07:26PM  
Nov-29-21 01:34PM  
Nov-26-21 07:26AM  
Nov-25-21 03:00PM  
Nov-22-21 11:40AM  
Nov-18-21 09:00AM  
Nov-15-21 10:52AM  
Nov-11-21 09:01AM  
Nov-10-21 05:45PM  
Nov-05-21 11:40AM  
Nov-03-21 07:30AM  
Nov-02-21 04:15PM  
Oct-18-21 01:42PM  
Oct-12-21 08:00AM  
Oct-06-21 11:40AM  
Sep-10-21 11:40AM  
Sep-03-21 09:52AM  
Sep-02-21 05:35PM  
Aug-31-21 11:23AM  
Aug-27-21 08:17AM  
Aug-26-21 03:00PM  
Aug-25-21 12:10PM  
Aug-19-21 09:36AM  
Aug-16-21 08:13AM  
Aug-13-21 03:16AM  
Aug-12-21 04:15PM  
Jul-29-21 04:15PM  
Jul-21-21 11:40AM  
Jul-14-21 04:15PM  
Jul-07-21 02:18AM  
Jul-05-21 11:40AM  
Jun-28-21 09:36AM  
Jun-21-21 12:02PM  
Jun-18-21 11:40AM  
Jun-15-21 04:15PM  
Jun-04-21 11:33AM  
Jun-03-21 04:15PM  
Jun-01-21 09:32AM  
May-31-21 07:24AM  
May-30-21 02:56AM  
May-29-21 04:11PM  
May-27-21 03:35PM  
May-25-21 08:00AM  
May-21-21 12:00PM  
May-12-21 04:15PM  
May-05-21 03:24PM  
May-03-21 04:15PM  
May-02-21 04:10AM  
Apr-29-21 04:15PM  
Apr-14-21 05:02PM  
Apr-06-21 06:51PM  
Apr-02-21 08:00AM  
Mar-25-21 12:00PM  
Mar-24-21 04:15PM  
Mar-22-21 06:19PM  
Mar-18-21 08:30AM  
Mar-17-21 01:32PM  
Mar-14-21 04:08PM  
Mar-11-21 12:53PM  
Mar-10-21 11:16PM  
Mar-08-21 06:02AM  
Mar-06-21 02:10AM  
Mar-05-21 12:04PM  
Mar-04-21 05:35PM  
Mar-03-21 10:38AM  
Mar-02-21 04:15PM  
Mar-01-21 04:15PM  
Feb-22-21 02:45PM  
Feb-18-21 04:15PM  
Feb-08-21 08:43AM  
Feb-05-21 09:55AM  
The Cooper Companies, Inc. operates as a medical device company worldwide. It operates through two segments, CooperVision and CooperSurgical. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. It also provides range of products and services for enhancing health of women, babies, and families, including medical devices, fertility, genomics, and diagnostics and contraception for hospitals and surgical centers, obstetricians' and gynecologists' (OB/GYNs) medical offices, and fertility clinics. In addition, the company develops mechanical surgical solutions for skin closure; and offers PARAGARD, a contraceptive, as well as provides assisted reproductive technology products, genetic screening and testing, and products within the general OB/GYN offerings. It markets its products under Biofinity, clariti 1day, MyDay, Avaira Vitality, and Proclear 1 Day brand name through a network of field sales representatives, independent agents, eye care practitioners, and distributors. The Cooper Companies, Inc. was founded in 1980 and is headquartered in San Ramon, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PETERSMEYER GARY SDirectorSep 15Option Exercise161.371,800290,4661,500Sep 15 07:29 PM
PETERSMEYER GARY SDirectorSep 15Sale441.35455200,8131,472Sep 15 07:29 PM
PETERSMEYER GARY SDirectorSep 15Sale440.731,800793,3160Sep 15 07:29 PM
Andrews Brian GEVP, CFO & TreasurerSep 07Option Exercise141.824,963703,8294,467Sep 07 06:34 PM
McBride Daniel GEVP, COO & Pres-CooperVisionSep 07Option Exercise136.5972,6249,919,557104,677Sep 07 06:40 PM
Andrews Brian GEVP, CFO & TreasurerSep 07Sale453.124,9632,248,8301,900Sep 07 06:34 PM
McBride Daniel GEVP, COO & Pres-CooperVisionSep 07Sale450.1372,62432,690,35532,115Sep 07 06:40 PM
PETERSMEYER GARY SDirectorJul 12Sale412.28400164,9121,927Jul 12 07:29 PM
Lindell Jody SDirectorJul 02Option Exercise98.454,500443,02518,043Jul 06 05:03 PM
Lindell Jody SDirectorJul 02Sale405.544,5001,824,91913,543Jul 06 05:03 PM
Ricupati AgostinoSVP, Fin & Tax; Chief Actg OffJul 01Option Exercise0.0034801,449Jul 01 06:32 PM
Ricupati AgostinoSVP, Fin & Tax; Chief Actg OffJun 17Option Exercise174.522,200383,9363,288Jun 17 07:06 PM
Ricupati AgostinoSVP, Fin & Tax; Chief Actg OffJun 17Sale385.552,200848,2171,101Jun 17 07:06 PM
Sheffield Holly RPresident, CSIJun 04Option Exercise0.001,10502,774Jun 07 05:13 PM
Ricupati AgostinoSVP, Fin & Tax; Chief Actg OffApr 15Option Exercise153.461,854284,5142,709Apr 15 06:37 PM
Ricupati AgostinoSVP, Fin & Tax; Chief Actg OffApr 15Sale397.922,6431,051,6991,088Apr 15 06:37 PM
WEISS ROBERT SDirectorApr 01Option Exercise0.00989063,798Apr 05 04:57 PM
PETERSMEYER GARY SDirectorApr 01Option Exercise0.0098902,327Apr 05 04:56 PM
MADDEN TERESA SDirectorApr 01Option Exercise0.002690356Apr 05 04:53 PM
Lindell Jody SDirectorApr 01Option Exercise0.00989013,543Apr 05 04:52 PM
KOZY WILLIAM ADirectorApr 01Option Exercise0.0098904,917Apr 05 04:50 PM
Jay ColleenDirectorApr 01Option Exercise0.0098904,647Apr 05 04:47 PM
White Albert G IIIPresident & CEOMar 08Option Exercise128.6679,74510,259,985121,175Mar 08 06:32 PM
White Albert G IIIPresident & CEOMar 08Sale388.6279,74530,990,53341,430Mar 08 06:32 PM
Auerbach Robert DSpecial Advisor to the CEOFeb 01Option Exercise0.0059203,049Feb 02 06:18 PM
Auerbach Robert DSpecial Advisor to the CEOJan 08Option Exercise0.002,10902,847Jan 12 05:04 PM
Ricupati AgostinoSVP, Fin & Tax; Chief Actg OffJan 08Option Exercise0.0087102,538Jan 12 05:02 PM
Drury Mark JVP, General Counsel & Sec.Jan 08Option Exercise0.001,12701,535Jan 12 04:58 PM
Andrews Brian GEVP, CFO & TreasurerJan 08Option Exercise0.0044201,961Jan 12 04:55 PM
Sheffield Holly RPresident, CSIJan 08Option Exercise0.0058901,874Jan 12 04:53 PM